Facebook Pixel

StopAfib.org Applauds FDA Approval of Multaq®: A Safer Option for Atrial Fibrillation Patients

Rate This

We hear from so many afib patients every day about the trials, tribulations, and fears regarding being on the medication amiodarone, or their refusal to take it. Since the FDA approved Multaq® (dronedarone) recently, the most frequent question I've fielded has been "When will Multaq® be available?" That happened this week, and the excitement they have shared with us has been palpable.

So, on behalf of the atrial fibrillation patient community, StopAfib.org felt it was appropriate to thank and applaud the U.S. Food and Drug Administration (FDA) for providing a safer option for those with atrial fibrillation and atrial flutter. Dronedarone is the first new anti-arrhythmic drug approved in years for afib. There are now more options for fighting that afib beast. Read more:

StopAfib.org Applauds the FDA for Providing a Safer Option for Those with Atrial Fibrillation and Atrial Flutter

Mellanie True Hills Bio: https://www.empowher.com/users/mellanie-true-hills

Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Enter the characters shown in the image.
By submitting this form, you agree to EmpowHER's terms of service and privacy policy

We value and respect our HERWriters' experiences, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice, although we hope you can gain knowledge from their insight.

Atrial Fibrillation

Get Email Updates

Atrial Fibrillation Guide

Have a question? We're here to help. Ask the Community.


Health Newsletter

Receive the latest and greatest in women's health and wellness from EmpowHER - for free!